Artículos
Study of Binding Kinetics and Specificity of 99mTc-SSS-Complex and 99mTc-HMPAO to Blood Cells
Contrast Media Mol Imaging. 2018 Oct 25;2018:5603902.
Nuclear Medicine in prostate cancer: A new era for radiotracers
World J Nucl Med. 2018 Apr-Jun; 17(2): 70–78.
Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6
ACS Omega 2018, 3, 2428−2436
Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation
Am J Nucl Med Mol Imaging 2018;8(3):200-227
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals
Molecules 2018, 23(3), 661. doi:10.3390/molecules23030661
Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.
RSC Adv. 2017 Oct 24; 7(78): 49586–49599
Targeted α Therapies for the Treatment of Bone Metastases.
Int. J. Mol. Sci. 2018, 19(1), 74
Jens Cardinale et al. Pharmaceuticals 2017, 10(4), 77; doi:10.3390/ph10040077
Khoramrouz SJ et al. Iran J Pharm Res. 2017 Spring;16(2):611-618.
Theranostics in nuclear medicine practice.
Anna Yordanova et al. Onco targets Ther. 2017; 10: 4821–4828
Mendoza-Nava et al. Mol Imaging. 2017 Jan-Dec; 16: 1536012117704768
Frank Rösch, Hans Herzog, Syed M. Qaim. Pharmaceuticals 2017, 10(2), 56; doi:10.3390/ph10020056
New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.
Kenneth Dahl, Christer Halldin, Magnus Schou. Clin Transl Imaging. 2017; 5(3): 275–289; doi: 10.1007/s40336-017-0223-1
Kang-Hung Chao et al. Hellenic Journal of Nuclear Medicine. January-April 2017
Kelly, J., Amor-Coarasa, A., Nikolopoulou, A. et al. Eur J Nucl Med Mol Imaging (2017) 44: 647. doi:10.1007/s00259-016-3556-5
Targets and probes for non-invasive imaging of β-cells.
Jodal, A., Schibli, R. & Béhé, M. Eur J Nucl Med Mol Imaging (2017) 44: 712. doi:10.1007/s00259-016-3592-1
Umbricht et al. EJNMMI Research (2017) 7:9
Anxo Fernández-Ferreiro et al. Eur J Pharm Biopharm, 114: 317–323, mayo 2017
New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.
Kenneth Dahl, Christer Halldin, Magnus Schou. Clinical and Translational Imaging, 2017
Li KP, Hu MK, Cheng CY, Hsu LF, Chou TK, Shiue CY, Shen DHJ Med Sci 2017;37:7-11
European Journal of Medical Physics.Feb 2017
Molecular Imaging and Biology, 2017 Feb
Mueller D, Kulkarni H, Baum RP, Odparlik A. Appl Radiat Isot. 2017 Jan 9;122:72-77
Potential ways to address shortage situations of Mo-99/Tc-99m.
Filzen L, Ellingson L, Paulsen A, Hung J. J Nucl Med Technol. 2017 Feb 2.
Oliveira JM, Gomes C, Faria DB, Vieira TS, Silva FA, Vale J, World J Nucl Med 2017;16:3-7.
SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.
X.Wang et alia. Oncotarget, Jan 2017.
Are we “preparing” radiopharmaceuticals?
Decristoforo, C. & Patt, M. EJNMMI radiopharm. chem. (2017) 1: 12
van der Pol J, Vöö S, Bucerius J, Mottaghy FM. Eur J Nucl Med Mol Imaging. 2017 Mar 16
Marylaine Pérez-Malo Cruz, René Leyva Montaña, José Morín Zorrilla. Nucleus- Ciencias Nucleares.nº 59. Cuba.2016
Alteraciones en la biodistribución de los radiofármacos causadas por interacciones medicamentosas
ALASBIMN Journal 4 de mayo de 2012
A Review on Therapeutic Approach of Radiopharmaceutical in Health Care System
International Journal of Pharmaceutical & Biological Archives 2012; 3(3):487-492
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2269-81
The options for the future production of the medical isotope 99Mo
Eur J Nucl Med Mol Imaging (2010) 37:1817–1820
J Nucl Med Technol. 2010 Sep;38(3):153-62.
Rev Esp Med Nucl. 2010 May-June;29(3):114-121.
Eur J Nucl Med Mol Imaging. 2010 April;37(4):835-41.
Nucl Med Commun. 2009 Jul 23.
Labeling of antibiotics for infection diagnosis
Q J Nucl Med Mol Imaging. 2006 Jun;50(2):147-52.
Control de calidad de activímetros
Rev Esp Med Nucl. 2004;23(6):434-43.
Alternative quality control for technetium-99m IDA complexes
Applied radiation and isotopes. 2004;61:1151-55.
Método rápido de marcaje de leucocitos con 99mTc-HMPAO
Rev Esp Med Nucl. 2002;21(5):343-8.
Rev Esp Med Nucl. 2001;20(3):477-98.
Labelling of platelets with indium-111 oxine and technetium-99m HMPAO: suggested methods
Eur J Nucl Med. 1999;26(12):1614-1616.
Drug interactions with radiopharmaceuticals
Eur J Nucl Med. 1994;21:348-356